NCT07195916 2026-02-10A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological MalignanciesIncyte CorporationPhase 1 Recruiting280 enrolled
NCT04459273 2026-02-05FAPI PET RDRCJonsson Comprehensive Cancer CenterPhase 1 Active not recruiting26 enrolled
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled
NCT01222780 2020-01-18To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory CancerAcrotech Biopharma Inc.Phase 1 Completed22 enrolled
NCT00900614 2019-07-31Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate CancerAprea TherapeuticsPhase 1 Completed36 enrolled
NCT01183663 2016-06-03Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)M.D. Anderson Cancer CenterPhase 1 Completed180 enrolled